Valores de linfocitos T Activos en pacientes con Bocio Tóxico difuso (Graves-Basedow)
PDF (Español (España))


linfocitos T Activos
bocio tóxico difuso

How to Cite

Uriarte, A., & Alavez, E. (2018). Valores de linfocitos T Activos en pacientes con Bocio Tóxico difuso (Graves-Basedow). Revista Colombiana De Endocrinología, Diabetes &Amp; Metabolismo, -12(1), 28–32.


Los valores de linfocitos T de alta afinidad por los glóbulos rojos de carnero (linfocitos T activos) están significativamente disminuídos en pacientes con Bocio Tóxico Difuso (BTD), lo que sugiere una evidencia más, de alteración de la inmunidad mediada por células en esta enfermedad.

No existen diferencias en los valores de linfocitos T totales y linfocitos B entre personas normales y con BTD.


Active T - lymphocyte values in patients with diffuse toxic goiter (Graves - Besedow)

The values of T - lymphocyte with high affinity for sheep red blood ells (active T-lymphocytes) are significantly decreased in patients with Difusse Toxic Goiter (DTG), suggesting once more the alterations in all - mediated in munity in this disease.

There are no differences between values of total T - lymphocytes and B - lymphocytes among normal person and those with DTB.
PDF (Español (España))


1. Mori. T. and Kriss, J.P. Measurements by competitive binding radioassay of serum anti-microsomal and anti-thyroglobulin antibodies in Graves' disease and other thyroid disorders. J. Clin. Endocr. Metab. 33; 668, 1971.
2. McKenzie, J. M.: Humoral factors in the pathogenesis of Graves´ disease. Physiological Reviews, 48. 252, 1968
3. Lamki, L. Row, V.V. Wolpe, R.: Cell-mediated immunity in Graves' disease and in Hashimoto's thyroiditis as shown by the demonstration inhibition factor (MIF) J. Clin. Endocrinol Meso. 36:358, 1973.
4. Wolpé, R., Fardd, N.R., Won Westar, C., Row, V.V.: The pathogenesis of Graves' disease and Hashimoto thyroiditis. Clin. Endocrinol. 3: 239, 1974.
5. Wybran J. and Fudenberg, H.H.: Thymus derived rosette - forming cells in various human disease states.: Cancer, lymphoma, bacterial and other disease. J. Clin. Invest. 52; 1026, 1973
6. Wybran, J. Can, M.C., and Fudenberg, H.H. The human rosette forming cell as a marker of a population of thymus derived cells. J. Clin. Invest. 51: 2537, 1972.
7. Meziharadsky, J. and Babusikova, O. Disminished in vitro effect of phyrohaemoaglutinin of lymphocytes of rats bearing singenic tumours, Neoplasma. 20, 4, 1973.
8. Urbanak, S.J., Penhake, W.J., Irvine, W.J. Peripheral blood T and B lymphocytes in patients with thyrotoxicosis and Hashimoto's thyroiditis and in normal subjects: a comparison of lymphocytes separation methods. Clin. Exp. Immunol. 18: 449, 1974.
9. Calder E.A. Urbaniak, S.J., Irvine, W.J., and James, K.: The effect of anti-alpha 2 macroglobulin on K cell cytolisis and T and B cells rosette formation. Clin. Exp. Immunol. 22, 112. 1975.
10. Siegels Diseño experimental no paramétrico. Pag. 64, 1970.
11. Faraid. N. R. Munro, R.E. Row. V.V. Volpé, R. Peripheral thymus dependent (T) lymphocytes in Graves' disease and Hashimoto' thyroiditis. N. Engl. J. Med. 288: 1313, 1973.
12. Aoki, N. Wakisaki. G. Nagata.I.: increase of T cells in Graves' disease. Lancet. 2:49, 1973. 13.
13. Wara, D.W., Reiter, E.D., Ammans, J.A.: T cell rosettes in thyrotoxic Graves' disease, N. Engl. J. Med. 289; 1145, 1973.
14. Volpé. R. Row. V.V., Proportion of E rosettes normal in Graves' and Hashimoto's diseases: a retraccion, N. Engl. J. Med. 293. 44, 1975.
15. Felsburg. P.J. Edelman, R. and Gilman. R.H.: The active E rosette test: Correlation with delayed cutaneous hypersensitivity. J. Immunol. 116. 1110, 1976.

Authors must state that they reviewed, validated and approved the manuscript's publication.  Moreover, they must sign a model release that should be sent.  A copy may be reviewed here




Download data is not yet available.